Pulseon®: natural ingredient for appetite suppression in frozen products
PulseON® is a natural ingredient designed to enhance GLP-1 responses, offering appetite suppression benefits when incorporated into frozen food products. Ongoing studies aim to validate its compatibility and bioefficacy across diverse formulations.
Overview
PulseON® is an innovative natural ingredient aimed at enhancing GLP-1 and PYY responses, crucial for appetite suppression. Initial studies have shown promising results when PulseON® is incorporated into bread products, boosting its potential as a natural appetite suppressant. The current research seeks to extend these benefits to a range of frozen products, maintaining product quality and bioefficacy through various formulations.
Technical specifications
- Incorporation: PulseON® is tested at 20-60% inclusion rates in frozen products.
- Benefits: Enhances GLP-1 and PYY responses, crucial hormones for appetite regulation.
- Testing Procedures: Laboratory methods such as texture analysis and plant cell integrity assessments ensure the ingredient retains its effectiveness post freeze-thaw cycles.
- Product Development: Includes sensory testing against control products and biophysical analyses to understand formulation impacts.
Technology readiness level
PulseON® is currently at Technology Readiness Level 5, indicating that it has been validated in relevant environments. Further studies and product formulations are planned to optimize its application in a broader range of frozen food products.
About Quadram Institute
Quadram Institute is a publicly funded bioscience research institute with around 300 researchers, connecting fundamental science with clinical and commercial translation. Its purpose-built Norwich facility places research laboratories alongside an NHS endoscopy centre and clinical research facility, enabling interaction among scientists, clinicians, patients, and research volunteers. At the heart of Norwich Research Park, it benefits from close proximity to the University of East Anglia, a major teaching hospital, other research institutes, and science-based businesses. Strategic support comes from BBSRC, part of UKRI, alongside national and international funders, charities, and industry. Business development, commercial scientific services, an industry advisory panel, and spinout support help move knowledge toward use.
delivered to your inbox.